Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Discovery, University of Washington Partner on Gene Editing Technology

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Horizon Discovery and the University of Washington today announced a two-year collaboration to create a gene editing process in inducible human pluripotent stem cells.

Under the terms of the deal, which builds on an agreement between the two parties in 2009, Horizon will fund a $400,000 research program at the university. In return, the Cambridge, UK-based firm receives exclusive rights to new intellectual property resulting from the work.

The collaboration will use rAAV, or recombinant adeno-associated virus, gene editing vectors to enable the creation of thousands of new X-Man cell models, which the partners said is the world's first source of genetically-defined and patient relevant human cell lines.

In 2008, Horizon reached an exclusive licensing agreement with the university covering a gene technology that is used to create the X-Man cell lines.

The research to be conducted under the current agreement will be led by David Russell, the inventor of rAAV-gene editing and a professor of medicine at the University of Washington School of Medicine.

In a statement, Horizon and the university said that the research will "enable the generation of diverse arrays of tissue-derived disease models for personalized medicine R&D applications, as well as optimized reagents for the production of biological drugs/materials and ex vivo-derived tissue therapies."

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.